ARTICLE | Company News
Nycomed, Acusphere cardiovascular deal
July 7, 2004 7:00 AM UTC
Nycomed (Roskilde, Denmark) licensed from ACUS exclusive rights to develop and market AI-700 in Europe. AI-700 is a synthetic porous microparticle polymer ultrasound contrast agent. ...